Eli Lilly and Company logo LLY - Eli Lilly and Company

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 32
HOLD 10
SELL 2
STRONG
SELL
0
| PRICE TARGET: $1151.07 DETAILS
HIGH: $1300.00
LOW: $830.00
MEDIAN: $1191.00
CONSENSUS: $1151.07
UPSIDE: 10.85%
Market Cap: 930.88B
Volume: 2,849,285
Avg Volume: 3,523,543
52 Week Range: 623.78-1133.95
Sector: Healthcare
Industry: Drug Manufacturers - General
Beta: 0.35
Last Dividend: $6.23
Exchange: NYSE
Country: US
Employees: 47,000
IPO Date: 1972-06-01
EPS (TTM): 11.76
P/E Ratio: 65.65
Revenue (TTM): 45.04B
Total Assets: 78.71B
Total Debt: 33.64B
Cash & Equiv: 3.27B
Rev Growth (5Y): 15.1%
EPS Growth (5Y): 6.2%
FCF Growth (5Y): -34.7%
ROCE: 26.7%
Debt/Equity: 2.37

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 45.04B 34.12B 28.54B 28.32B 24.54B 22.32B 21.49B 19.97B 21.22B 19.96B 19.62B 23.11B
Net Income 10.59B 5.24B 6.24B 5.58B 6.19B 8.32B 3.23B (204.10M) 2.74B 2.41B 2.39B 4.68B
EPS 11.76 5.83 6.57 5.85 6.47 8.69 3.14 -0.19 2.49 2.18 2.15 4.19
Total Assets 78.71B 64.01B 49.49B 48.81B 46.63B 39.29B 43.91B 44.98B 38.81B 35.57B 36.31B 35.25B
Total Debt 33.64B 25.23B 16.24B 16.88B 16.60B 15.80B 10.30B 13.65B 10.31B 7.98B 8.06B 5.21B
Cash & Equivalents 3.27B 2.82B 2.07B 3.82B 3.66B 2.34B 7.32B 6.54B 4.58B 3.67B 3.87B 3.83B
Operating Cash Flow 8.82B 4.24B 7.59B 7.37B 6.50B 4.84B 5.52B 5.62B 4.85B 2.96B 4.46B 5.74B
Free Cash Flow 414.30M (3.15B) 4.60B 5.39B 4.47B 3.48B 2.51B 3.45B 3.76B 1.34B 2.89B 4.64B
FCF per Share 0.46 -3.50 4.84 5.65 4.67 3.64 2.44 3.28 3.41 1.21 2.60 4.16
Book Value 14.19B 10.77B 10.65B 8.98B 5.64B 2.61B 9.83B 11.59B 14.01B 14.57B 15.37B 17.63B
Cash & ST Investments 3.42B 2.93B 2.21B 3.91B 3.68B 2.44B 7.41B 8.03B 6.04B 4.45B 4.83B 5.40B
ROC Equity 0.75 0.49 0.59 0.62 1.10 3.19 0.33 -0.02 0.20 0.17 0.16 0.27